Business Wire

CA-ZYNGA

27.5.2021 15:02:13 CEST | Business Wire | Press release

Share
Kenneth Cole and Zynga to Bring First-of-its-Kind Pride Month Partnership to Rollic's Hyper-Casual Game High Heels!

Kenneth Cole and Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, today announced a partnership to debut the Kenneth Cole PRIDE 2021 collection in the hit hyper-casual game High Heels! . This collaboration marks the first time that Kenneth Cole’s iconic street-smart style will be featured in a mobile game. For the first two weeks of June, gamers will be able to play with pride as they outfit their character and strut the virtual runway in product from the Kenneth Cole PRIDE 2021 collection, including the brand’s iconic KAM sneakers, shirts that proudly state “Being Different is What We Have in Common” and other accessories such as sunglasses, watches and mask lanyards.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210527005009/en/

At Kenneth Cole, there has always been a rich history of supporting public health and civil liberties. For almost 40 years, the man and the brand have nurtured and maintained a global culture of equity and inclusion. In 2020, Kenneth Cole founded The Mental Health Coalition, whose mission is to build a like-minded community that will work together to destigmatize all mental health conditions, enabling equitable access to vital resources and support for all. For every PRIDE product purchased on kennethcole.com, a percentage of net sales will be donated to The Mental Health Coalition. MHC is proud to offer resources specific to LGBTQ+ communities, including an LGBTQ+ mental health guide and the ability to connect with its member organizations for support.

“As a brand, we have been supporting equal rights for the LGBTQ+ community for almost 30 years. For our latest initiative, in recognition of Pride, we are proud to partner with Zynga, a company with shared values, to further highlight the importance of inclusion and acceptance,” said Kenneth Cole, Chairman and Chief Creative Officer of Kenneth Cole Productions, Inc. “We are including our PRIDE product in High Heels!, allowing millions of people to experience celebrating Pride, and as a reminder that ‘being different is what we have in common.’”

“At Zynga we believe, unequivocally, that our strength is in our diversity and that we are called to celebrate our differences. We are proud to stand in solidarity with the LGBTQ+ community in celebration of Pride Month,” said Frank Gibeau, Chief Executive Officer of Zynga. “We’re thrilled to be partnering with a revered, boundary-pushing brand like Kenneth Cole to increase representation in our games and empower players to show their pride, spirit and fashion in High Heels! ; it’s a perfect fit.”

Developed by Rollic, a subsidiary of Zynga, High Heels! has been downloaded over 60 million times and has been enthusiastically received all around the world. In the game, players maneuver an increasingly challenging catwalk in high heels, which stack higher as they complete levels. The stakes rise as players progress through a series of worldwide fashion shows in global cities including London, Beijing, Paris and New York. Earning access to new customization elements as they advance, players can update their character with new clothing, fashion, hairstyles and shoes.

High Heels! is available to download for free on the App Store as well as Google Play . Kenneth Cole PRIDE product is available on KennethCole.com . The 2021 PRIDE capsule includes:

  • KAM sneaker with rainbow stripe
  • T-shirt with rainbow graphic “Being Different is What We Have in Common”
  • Mask lanyards in rainbow
  • Sunglasses
  • Watch

Editor’s Note:
Photos of the collection and other key art from High Heels! can be downloaded here:
https://www.dropbox.com/sh/9kkjzkthgtwwh4y/AACIjzTt9saFabc74KqRF6gFa?dl=0

About Zynga Inc.
Zynga is a global leader in interactive entertainment with a mission to connect the world through games. To date, more than one billion people have played Zynga’s franchises including CSR Racing ™, Empires & Puzzles ™, Merge Dragons! ™, Merge Magic! ™, Toon Blast ™, Toy Blast ™, Words With Friends ™ and Zynga Poker ™. Zynga’s games are available in more than 150 countries and are playable across social platforms and mobile devices worldwide. Founded in 2007, the company is headquartered in San Francisco with locations in the U.S., Canada, U.K., Ireland, India, Turkey and Finland. For more information, visit www.zynga.com or follow Zynga on Twitter , Instagram , Facebook or the Zynga blog .

About Kenneth Cole Productions, Inc.
Kenneth Cole is an American designer, social activist, and visionary who believes business and philanthropy are interdependent. His global company, Kenneth Cole Productions, creates modern, functional, and versatile footwear, clothing, and accessories for inspirational urban lifestyles under the labels Kenneth Cole New York, Reaction Kenneth Cole, and Unlisted, as well as footwear under the label Gentle Souls. The company has also granted a wide variety of third party licenses for the production of men’s and women's apparel, fragrances, watches, jewelry, eyewear, and several other accessory categories, including children’s footwear. The company's products are distributed through department stores, better specialty stores, company-owned retail stores and its e-commerce website.

Over 35 years ago, Kenneth Cole leveraged his passion and unique brand platform to make a meaningful impact on people’s wardrobes, as well as communities in need. He did what others didn’t and said what others wouldn’t. Today, The Kenneth Cole Foundation remains committed to helping communities in need by supporting Public Health and Civil Liberties.

About Rollic
Founded in December 2018, Rollic is an Istanbul-based game developer and publisher, focused on free-to-play hyper-casual games for iOS and Android. Games released by Rollic include Blob Runner 3D, Flipper Dunk, Go Knots 3D, High Heels! , Onnect – Pair Matching Puzzle, Pixel Shot 3D, Picker 3D, Repair Master 3D, Tangle Master 3D, Water Shooty and Wheel Smash . Rollic is committed to producing massively appealing global titles while building a thriving developer ecosystem in the gaming industry. Rollic was acquired by Zynga, a global leader in interactive entertainment, in October 2020. For more information, visit www.rollicgames.com or follow Rollic on Facebook , LinkedIn , Instagram , Twitter or the Rollic blog .

Forward Looking Statements
This press release contains forward-looking statements, relating to, among other things, events and featuring in the game High Heels! . Forward-looking statements often include words such as “outlook,” “projected,” “planned,” “intends,” “will,” “anticipate,” “believe,” “target,” “expect,” and statements in the future tense are generally forward-looking. The achievement or success of the matters covered by such forward-looking statements involves significant risks, uncertainties, and assumptions. Undue reliance should not be placed on such forward-looking statements, which are based on information available to us on the date hereof. We assume no obligation to update such statements. More information about these risks, uncertainties, and assumptions is or will be described in greater detail in our public filings with the Securities and Exchange Commission (the “SEC”), copies of which may be obtained by visiting our Investor Relations website at http://investor.zynga.com or the SEC’s website at www.sec.gov .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Merz Therapeutics Announces Completion of Recruitment in Two Phase III Trials Investigating XEOMIN® (incobotulinumtoxinA) for Migraine Prevention15.10.2026 08:00:00 CEST | Press release

Patient recruitment completed six months ahead of schedule in two global Phase III trials for migraine prevention MINT-E and MINT-C are evaluating XEOMIN® (incobotulinumtoxinA) for the preventive treatment of episodic and chronic migraine Trials recruited approximately 1,800 adults across 109 study sites in North America and Europe Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced the completion of patient recruitment in two global Phase III clinical trials, MINT-E (NCT07018700) and MINT-C (NCT07018713), evaluating the efficacy and safety of XEOMIN® (incobotulinumtoxinA) for the prevention of episodic and chronic migraine in adults. The trials recruited approximately 1800 adults across 109 study sites in North America and Europe. Migraine affects around 1.1 billion people worldwide, posing a significant burden on patients, society and healthcare systems.1 Both trials are evaluating the change in monthly migraine days from baseline to Month

Tourism Malaysia and Alipay+ Partner to Accelerate Malaysia’s Digital Tourism Transformation15.10.2026 07:10:00 CEST | Press release

Collaboration will connect seamless payments, in-app digital engagement and AI-powered travel services to enhance the visitor journey, empower businesses of all sizes and unlock wider cross-border commerce opportunities Tourism Malaysia and Alipay+, the unified wallet gateway of Ant International, today signed a Memorandum of Understanding (MoU) to accelerate cross-border commerce and digitalise merchant engagement across Malaysia's tourism economy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014035900/en/ (From left) Mr Mohd Akbal Setia (Head of VM2026 Secretariat and Senior Director, Advertising & Digital Tourism); Mr Mohd Amirul Rizal Abdul Rahim (Director General, Tourism Malaysia); Mr Danny Chung (General Manager of Alipay+ Global Growth Center and Vice President of Ant International); Mr Michael Guo, Alipay+ General Manager of SEA, South Asia and ANZ, Ant International) As Malaysia welcomes visitors for Visit Mal

PeDRA 2026: Nemolizumab Phase II Data Show Long-Term Symptom Relief for Children Aged 2 to 11 Years With Moderate-to-Severe Atopic Dermatitis15.10.2026 07:00:00 CEST | Press release

Patient-reported outcomes from a phase II study of nemolizumab in children aged 2 to 11 with moderate-to-severe atopic dermatitis show meaningful reductions in itch severity, better sleep and improved quality of life, maintained for a year1 Currently, there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis, despite the high unmet need – the disease can significantly reduce quality of life for children and create burden on their families2-8 These findings expand on the clinical evidence base for nemolizumab, which has multiple global approvals for adult and pediatric patients 12 years of age and older with moderate-to-severe atopic dermatitis, and adults with prurigo nodularis9,10 Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new phase II data showing that nemolizumab provided meaningful improvements in itch, sleep disturbance, and quality of life in children aged 2 to 11 years with moderate-to-severe

Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 115.10.2026 02:30:00 CEST | Press release

− ORZEYFUL is now available in Japan and China following approvals within a month of each other by China’s National Medical Products Administration (NMPA), the U.S. Food and Drug Administration (FDA) and Japan’s Ministry of Health, Labour and Welfare (MHLW) − Discovered by Takeda scientists in Japan, ORZEYFUL is the lead medicine in Takeda’s orexin franchise, with multiple programs for sleep-wake disorders and conditions where orexin biology plays a role − ORZEYFUL set to launch next month in the U.S., following completion of DEA scheduling; Health Authority submissions underway worldwide Takeda (TSE:4502/NYSE:TAK)announced today that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (NT1), providing first access to clinicians to prescribe treatment with the new class of medicine. ORZEYFUL is a first-in-class orexin receptor 2 (OX2R) agonist, in tablet form, designed to treat the underlying orexin deficiency associated with NT1. “We’re ex

Celltrion to Spotlight Subcutaneous (SC) Infliximab (Remsima™ SC) and Broader IBD Portfolio at UEG Week 202615.10.2026 02:10:00 CEST | Press release

Celltrion to showcase its broad IBD portfolio, including Remsima™ IV, Remsima™ SC, the newly launched Remsima™ IV Liquid formulation, Steqeyma™ and Yuflyma™Symposium and Meet the Experts sessions to highlight long-term clinical evidence and real-world experience with subcutaneous (SC) infliximab (Remsima™ SC) across different IBD patient scenarios Celltrion, Inc. (KRX:068270) announced its participation in United European Gastroenterology (UEG) Week 2026, in Barcelona, Spain (Oct. 17-20), highlighting its inflammatory bowel disease (IBD) treatment portfolio, led by Remsima™ SC (subcutaneous infliximab). Celltrion will showcase its comprehensive infliximab portfolio, comprising Remsima™ intravenous (IV) and subcutaneous (SC) formulations, as well as the Remsima™ IV liquid formulation launched in Europe earlier this year.1 Additionally, the company will highlight its broader IBD portfolio, including SteQeyma™ (ustekinumab) and Yuflyma™ (adalimumab), reflecting its continued efforts to ex

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye